MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,588,359 | +65159.0% | 1,473,254 | -4.5% | 1.07% | -22.7% |
| Q2 2023 | $7,031 | -16.3% | 1,542,743 | -9.7% | 1.39% | -19.2% |
| Q1 2023 | $8,405 | -3.9% | 1,708,348 | +3.6% | 1.72% | -8.4% |
| Q4 2022 | $8,749 | -99.9% | 1,648,238 | -11.7% | 1.88% | -17.5% |
| Q3 2022 | $11,880,000 | +14.0% | 1,867,113 | -17.3% | 2.28% | +23.3% |
| Q2 2022 | $10,423,000 | -29.8% | 2,258,500 | +7.5% | 1.85% | -5.3% |
| Q1 2022 | $14,849,000 | -39.9% | 2,100,000 | -13.1% | 1.95% | +1.1% |
| Q4 2021 | $24,702,000 | -11.7% | 2,415,500 | +4.8% | 1.93% | -11.3% |
| Q3 2021 | $27,978,000 | – | 2,305,500 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |